Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

CVS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against CVS Health Corporation - CVS

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2019 | 10:51pm EST

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until October 14, 2019 to file lead plaintiff applications in a securities class action lawsuit against CVS Health Corporation (NYSE: CVS) if they formerly held shares of Aetna Inc. that were exchanged for shares of CVS in connection with the November 2018 acquisition of Aetna by CVS. This action is pending in the United States District Court for the District of Rhode Island.

What You May Do

If you exchanged shares of Aetna for CVS shares as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-cvs/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by October 14, 2019.

About the Lawsuit

On March 13, 2018, shareholders of Aetna, Inc. approved its acquisition by CVS, receiving CVS stock valued at $80/share as part consideration. Subsequently, in August 2018 and again in February 2019, CVS disclosed the recording of impairment charges of $3.9B and $2.2B, respectively, related to its 2015 acquisition of Omnicare, Inc., sending shares of CVS plummeting.

The case is Waterford Township Police & Fire Ret. Sys. v. CVS Health Corp., et al., 19-cv-00434.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
12/13BRISTOL MYERS SQUIBB : Myers Executive VP Elicker to Retire; CVS's Metcalfe Taki..
DJ
12/12CVS HEALTH : Announces $750K in New Funding for California Harm Reduction Coalit..
PR
12/12CVS HEALTH : Thinking about buying stock in Camber Energy, CVS, Dropbox, FuelCel..
PR
12/12CVS HEALTH : Launches Transform Oncology Care™ Program to Help Improve Pat..
PR
12/11New York Life Makes Bid for Cigna Unit -- WSJ
DJ
12/09CVS HEALTH : Completes Rollout of Time Delay Safes in All of Its West Virginia P..
PR
12/05AETNA FOUNDATION : Announces $1 Million in Grants to Boys & Girls Clubs in Provi..
PR
12/05CVS HEALTH : Announces Successful First Year of Aetna Integration at One Year An..
PR
12/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
12/02Health Care Down On Regulatory, Litigation Concerns -- Health Care Roundup
DJ
More news
Financials (USD)
Sales 2019 254 B
EBIT 2019 15 044 M
Net income 2019 6 575 M
Debt 2019 62 782 M
Yield 2019 2,71%
P/E ratio 2019 14,7x
P/E ratio 2020 13,1x
EV / Sales2019 0,62x
EV / Sales2020 0,59x
Capitalization 95 738 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 80,81  $
Last Close Price 73,59  $
Spread / Highest target 25,0%
Spread / Average Target 9,81%
Spread / Lowest Target -17,1%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President